July 08, 2025

Melanomas: Clinical Decision Making with AI

Artificial intelligence support for opticians assessing small pigmented choroidal lesions

The Ophthalmologist

July 04, 2025

Respiratory Disease: From Scarcity to Solutions

How low-resource-focused innovations in biomarker diagnostics are shaping the future of global health

The Pathologist

July 03, 2025

Quiz Time!

How much do you know about neuroblastoma?

The Pathologist

July 02, 2025

UK Plans Nationwide DNA Sequencing of Newborns

The scheme aims to prevent disease, but some experts are skeptical

The Analytical Scientist

July 02, 2025

Can Genetic Testing Identify the Best Treatment for Metastatic, Castration-Resistant Prostate Cancer?

Patients with metastatic, castration-resistant prostate cancer (mCRPC) have a median overall survival of only about two to three years, but genomic sequencing is making inroads against that grim prognosis.

Roswell Park Comprehensive Cancer Center

July 01, 2025

Survey Shows Inaccuracies in U.S. Perceptions of Testicular Cancer

Only about 13% of U.S. adults correctly reported that testicular cancer is most common among men younger than 40.

The ASCO Post

July 01, 2025

The Optimism of Optogenetics

Several companies are sponsoring clinical development of optogenetic therapies, each with distinct approaches and technologies.

Ophthalmology Management

July 01, 2025

Getting YAG in the Bag: Tips for Success

Joe Munsell, OD, dedicated part of his 2025 Optometry’s Meeting lecture, “Optometric Laser Procedures: Pearls, Pitfalls, and How to Successfully Incorporate Into Your Practice,” to clinical pearls related to the procedure.

Optometric Management

July 01, 2025

Dr. Shannon Boye

Atsena Therapeutics’ founder and chief scientific officer discusses her role as CSO, the latest developments with ATSN-101, trends in the ocular gene therapy space, and more.

Ophthalmology Management